Cancer Research Meeting Calendar  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 67, 5201, June 1, 2007. doi: 10.1158/0008-5472.CAN-06-4647
© 2007 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Singh, P. K.
Right arrow Articles by Hollingsworth, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Singh, P. K.
Right arrow Articles by Hollingsworth, M. A.

Cell, Tumor, and Stem Cell Biology

Platelet-Derived Growth Factor Receptor ß–Mediated Phosphorylation of MUC1 Enhances Invasiveness in Pancreatic Adenocarcinoma Cells

Pankaj K. Singh1,2, Yunfei Wen1,2, Benjamin J. Swanson1, Kandavel Shanmugam3, Andrius Kazlauskas4, Ronald L. Cerny5, Sandra J. Gendler3 and Michael A. Hollingsworth1,2

1 Eppley Institute for Research in Cancer and Allied Diseases and 2 Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, Nebraska; 3 Department of Biochemistry/Molecular Biology Program, Mayo Clinic College of Medicine, Scottsdale, Arizona; 4 Schepens Eye Research Institute, Harvard Medical School, Boston, Massachusetts; and 5 University of Nebraska-Lincoln, Lincoln, Nebraska

Requests for reprints: Michael A. Hollingsworth, Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, 986805 Nebraska Medical Center, Omaha, NE 68198-6805. Phone: 402-559-8343; Fax: 402-559-3339; E-mail: mahollin{at}unmc.edu.

MUC1 is a heterodimeric transmembrane glycoprotein that is overexpressed and aberrantly glycosylated in ductal adenocarcinomas. Differential phosphorylation of the MUC1 cytoplasmic tail (MUC1CT) has been associated with signaling events that influence the proliferation and metastasis of cancer cells. We identified a novel tyrosine phosphorylation site (HGRYVPP) in the MUC1CT by mass spectrometric analysis of MUC1 from human pancreatic adenocarcinoma cell lines. Analyses in vitro and in vivo showed that platelet-derived growth factor receptor ß (PDGFRß) catalyzed phosphorylation of this site and of tyrosine in the RDTYHPM site. Stimulation of S2-013.MUC1F cells with PDGF-BB increased nuclear colocalization of MUC1CT and ß-catenin. PDGF-BB stimulation had no significant effect on cell proliferation rate; however, it enhanced invasion in vitro through Matrigel and in vivo tumor growth and metastases. Invasive properties of the cells were significantly altered on expression of phosphorylation-abrogating or phosphorylation-mimicking mutations at these sites. We propose that interactions of MUC1 and PDGFRß induce signal transduction events that influence the metastatic properties of pancreatic adenocarcinoma. [Cancer Res 2007;67(11):5201–10]




This article has been cited by other articles:


Home page
Cancer Res.Home page
T. W. Poh, J. M. Bradley, P. Mukherjee, and S. J. Gendler
Lack of Muc1-Regulated {beta}-Catenin Stability Results in Aberrant Expansion of CD11b+Gr1+ Myeloid-Derived Suppressor Cells from the Bone Marrow
Cancer Res., April 15, 2009; 69(8): 3554 - 3562.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
K. C. Kim and E. P. Lillehoj
MUC1 Mucin: A Peacemaker in the Lung
Am. J. Respir. Cell Mol. Biol., December 1, 2008; 39(6): 644 - 647.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. K. Singh, M. E. Behrens, J. P. Eggers, R. L. Cerny, J. M. Bailey, K. Shanmugam, S. J. Gendler, E. P. Bennett, and M. A. Hollingsworth
Phosphorylation of MUC1 by Met Modulates Interaction with p53 and MMP1 Expression
J. Biol. Chem., October 3, 2008; 283(40): 26985 - 26995.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
M.-K. Shyu, M.-C. Lin, C.-H. Liu, Y.-R. Fu, J.-C. Shih, C.-N. Lee, H.-Y. Chen, J. Huang, M.-C. Huang, and F.-J. Hsieh
MUC1 Expression Is Increased During Human Placental Development and Suppresses Trophoblast-Like Cell Invasion In Vitro
Biol Reprod, August 1, 2008; 79(2): 233 - 239.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
D. D. Carson
The Cytoplasmic Tail of MUC1: A Very Busy Place
Sci. Signal., July 8, 2008; 1(27): pe35 - pe35.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
Q. Shen, J. J. Rahn, J. Zhang, N. Gunasekera, X. Sun, A. R.E. Shaw, M. J. Hendzel, P. Hoffman, A. Bernier, and J. C. Hugh
MUC1 Initiates Src-CrkL-Rac1/Cdc42-Mediated Actin Cytoskeletal Protrusive Motility after Ligating Intercellular Adhesion Molecule-1
Mol. Cancer Res., April 1, 2008; 6(4): 555 - 567.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Z. Wang, D. Kong, S. Banerjee, Y. Li, N. V. Adsay, J. Abbruzzese, and F. H. Sarkar
Down-regulation of Platelet-Derived Growth Factor-D Inhibits Cell Growth and Angiogenesis through Inactivation of Notch-1 and Nuclear Factor-{kappa}B Signaling
Cancer Res., December 1, 2007; 67(23): 11377 - 11385.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2007 by the American Association for Cancer Research.